223 related articles for article (PubMed ID: 10500653)
1. Usefulness of the switch to tacrolimus in liver transplantation.
González-Pinto I; Alonso O; Loinaz C; Gómez R; Rodríguez-Cañete A; Rodríguez F; Pérez-Saborido B; Paseiro G; Moreno-González E
Transplant Proc; 1999 Sep; 31(6):2425-6. PubMed ID: 10500653
[No Abstract] [Full Text] [Related]
2. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study.
Mühlbacher F;
Transplant Proc; 2001; 33(1-2):1339-40. PubMed ID: 11267317
[No Abstract] [Full Text] [Related]
3. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
Bechstein WO; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Ericzon BG; Bismuth H
Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
[No Abstract] [Full Text] [Related]
4. Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group.
Wiesner RH
Transplant Proc; 1998 Jun; 30(4):1399-400. PubMed ID: 9636565
[No Abstract] [Full Text] [Related]
5. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].
Arnold JC; Theilmann L
Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559
[No Abstract] [Full Text] [Related]
6. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
[No Abstract] [Full Text] [Related]
7. Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy.
Ben-Ari Z; Mor E; Shaharabani E; Bar-Nathan N; Shapira Z; Tur-Kaspa R
Transplant Proc; 2000 Jun; 32(4):709-10. PubMed ID: 10856553
[No Abstract] [Full Text] [Related]
8. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
Transplant Proc; 1993 Feb; 25(1 Pt 1):641-3. PubMed ID: 7679828
[No Abstract] [Full Text] [Related]
9. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus in solid organ transplantation: an update.
Shapiro R
Transplant Proc; 1999 Sep; 31(6):2203-5. PubMed ID: 10500545
[No Abstract] [Full Text] [Related]
11. Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles.
Henry ML
Clin Transplant; 1999 Jun; 13(3):209-20. PubMed ID: 10383101
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus (FK506) is superior to cyclosporine in liver transplantation.
Busuttil RW; Holt CD
Transplant Proc; 1997; 29(1-2):534-8. PubMed ID: 9123119
[No Abstract] [Full Text] [Related]
13. Tacrolimus is superior to cyclosporine in liver transplantation.
Busuttil RW; Holt CD
Transplant Proc; 1998 Aug; 30(5):2174-8. PubMed ID: 9723432
[No Abstract] [Full Text] [Related]
14. More effective immunosuppression with the use of FK506 after liver transplantation.
Lo CM; Fan ST; Liu CL; Ng IO; Lam BK; Yong BH; Lai CL; Lau GK; Wong J
Transplant Proc; 2000 Nov; 32(7):2269-70. PubMed ID: 11120161
[No Abstract] [Full Text] [Related]
15. Optimization of the use of Calcineurin inhibitors in liver transplantation.
de Mare-Bredemeijer EL; Metselaar HJ
Best Pract Res Clin Gastroenterol; 2012 Feb; 26(1):85-95. PubMed ID: 22482528
[TBL] [Abstract][Full Text] [Related]
16. Histopathological findings according to Banff-97 classification system comparing tacrolimus versus cyclosporine.
Rodrigo E; Escallada R; Fernández-Fresnedo G; Ruiz JC; Piñera C; Herráez I; Cotorruelo JG; Zubimendi JA; de Francisco AL; Arias M
Transplant Proc; 2002 Aug; 34(5):1719-20. PubMed ID: 12176550
[No Abstract] [Full Text] [Related]
17. Neoral is superior to FK 506 in liver transplantation.
Levy GA
Transplant Proc; 1998 Aug; 30(5):1812-5. PubMed ID: 9723293
[No Abstract] [Full Text] [Related]
18. Comparison of cyclosporine A and FK506 with regard to complaints and psychosocial characteristics before and after liver transplantation.
Scholler G; Rose M; Neuhaus R; Neuhaus P; Klapp BF
Transplant Proc; 1997 Aug; 29(5):2491-3. PubMed ID: 9270822
[No Abstract] [Full Text] [Related]
19. Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients.
Blume C; Hollenbeck M; Ivens K; Heering P; Hetzel GR; Grabensee B
Transplant Proc; 2001; 33(7-8):3161-3. PubMed ID: 11750357
[No Abstract] [Full Text] [Related]
20. Conversion to neoral provides effective rescue therapy for liver and kidney transplant patients intolerant of Prograf.
Abouljoud M; Kumar MS; Brayman K; Emre S; Bynon SJ
Transplant Proc; 2001; 33(1-2):1027-8. PubMed ID: 11267175
[No Abstract] [Full Text] [Related]
[Next] [New Search]
